Intellipharmaceutics International Inc. (IPCIQ)
OTCMKTS
· Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Mar 19, 2025
IPCIQ Balance Sheet
Financials in millions USD. Fiscal year is December - November.
Millions USD. Fiscal year is Dec - Nov.
Fiscal Year | TTM | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | 2013 - 2017 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '23 Aug 31, 2023 | Nov '22 Nov 30, 2022 | Nov '21 Nov 30, 2021 | Nov '20 Nov 30, 2020 | Nov '19 Nov 30, 2019 | Nov '18 Nov 30, 2018 | 2013 - 2017 |
| Cash & Equivalents | 0.4 | 0.08 | 0.77 | 0.2 | 0.06 | 6.64 | Upgrade
|
| Cash & Short-Term Investments | 0.4 | 0.08 | 0.77 | 0.2 | 0.06 | 6.64 | Upgrade
|
| Cash Growth | 402.33% | -89.15% | 282.06% | 212.66% | -99.03% | 250.11% | Upgrade
|
| Accounts Receivable | - | 0 | - | 0.07 | 0.18 | 0.24 | Upgrade
|
| Other Receivables | 0.27 | 0.27 | 0.27 | 0.98 | 0.78 | 1 | Upgrade
|
| Receivables | 0.27 | 0.27 | 0.27 | 1.05 | 0.95 | 1.24 | Upgrade
|
| Inventory | - | - | - | 0.11 | 0.35 | 0.25 | Upgrade
|
| Prepaid Expenses | 0.19 | 0.14 | 0.06 | 0.12 | 0.16 | 0.59 | Upgrade
|
| Total Current Assets | 0.86 | 0.49 | 1.1 | 1.48 | 1.52 | 8.72 | Upgrade
|
| Property, Plant & Equipment | 0.7 | 0.94 | 0.99 | 1.9 | 2.27 | 2.74 | Upgrade
|
| Other Intangible Assets | 0 | 0 | 0 | 0 | 0.01 | 0.01 | Upgrade
|
| Total Assets | 1.57 | 1.43 | 2.1 | 3.39 | 3.8 | 11.47 | Upgrade
|
| Accounts Payable | 3.86 | 3.76 | 3.78 | 4.1 | 3.76 | 2.64 | Upgrade
|
| Accrued Expenses | 7.25 | 5.89 | 4.14 | 2.85 | 1.42 | 0.58 | Upgrade
|
| Short-Term Debt | 2.18 | 2.16 | 1.92 | 1.96 | 1.9 | 0.44 | Upgrade
|
| Current Portion of Long-Term Debt | - | - | - | - | - | 1.35 | Upgrade
|
| Current Portion of Leases | 0.04 | 0.17 | - | 0.16 | - | - | Upgrade
|
| Current Income Taxes Payable | 0.03 | 0.03 | 0.02 | 0.04 | 0.01 | - | Upgrade
|
| Current Unearned Revenue | 0.21 | - | - | - | - | 0.3 | Upgrade
|
| Other Current Liabilities | 0.87 | - | 0.4 | 0.6 | 0.4 | - | Upgrade
|
| Total Current Liabilities | 14.44 | 12.01 | 10.25 | 9.7 | 7.49 | 5.31 | Upgrade
|
| Long-Term Unearned Revenue | - | - | - | - | - | 2.06 | Upgrade
|
| Total Liabilities | 14.44 | 12.01 | 10.25 | 9.7 | 7.49 | 7.37 | Upgrade
|
| Common Stock | 49.18 | 49.18 | 49.18 | 46.14 | 45.56 | 44.33 | Upgrade
|
| Additional Paid-In Capital | 45.1 | 45.1 | 44.63 | 44.35 | 44.17 | 45.11 | Upgrade
|
| Retained Earnings | -107.43 | -105.13 | -102.24 | -97.1 | -93.71 | -85.62 | Upgrade
|
| Comprehensive Income & Other | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | 0.28 | Upgrade
|
| Shareholders' Equity | -12.88 | -10.58 | -8.16 | -6.31 | -3.69 | 4.1 | Upgrade
|
| Total Liabilities & Equity | 1.57 | 1.43 | 2.1 | 3.39 | 3.8 | 11.47 | Upgrade
|
| Total Debt | 2.22 | 2.33 | 1.92 | 2.11 | 1.9 | 1.79 | Upgrade
|
| Net Cash (Debt) | -1.82 | -2.24 | -1.15 | -1.91 | -1.84 | 4.85 | Upgrade
|
| Net Cash Growth | - | - | - | - | - | 699.79% | Upgrade
|
| Net Cash Per Share | -0.05 | -0.07 | -0.04 | -0.08 | -0.09 | 1.02 | Upgrade
|
| Filing Date Shares Outstanding | 33.09 | 33.09 | 33.09 | 23.68 | 23.68 | 21.93 | Upgrade
|
| Total Common Shares Outstanding | 33.09 | 33.09 | 33.09 | 23.68 | 22.09 | 18.25 | Upgrade
|
| Working Capital | -13.58 | -11.52 | -9.15 | -8.22 | -5.97 | 3.41 | Upgrade
|
| Book Value Per Share | -0.39 | -0.32 | -0.25 | -0.27 | -0.17 | 0.22 | Upgrade
|
| Tangible Book Value | -12.88 | -10.58 | -8.16 | -6.32 | -3.7 | 4.09 | Upgrade
|
| Tangible Book Value Per Share | -0.39 | -0.32 | -0.25 | -0.27 | -0.17 | 0.22 | Upgrade
|
| Machinery | 5.87 | 5.87 | 5.87 | 6.38 | 6.47 | 6.09 | Upgrade
|
| Leasehold Improvements | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 | 1.44 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.